FDA Authorizes Second COVID-19 Vaccine After Moderna Review

The US has set a new record for daily COVID-19 infections. The Moderna vaccine has received emergency use authorization, allowing for millions of doses to be distributed across the country. This follows the rollout of Pfizer's vaccine. Both vaccines require two doses and are over 90% effective. Moderna's vaccine, unlike Pfizer's, does not need extreme cold storage, making it more accessible to rural areas. Initial vaccinations will target frontline workers and high-risk groups, but supply is insufficient for all healthcare workers. Other professions are lobbying for inclusion in future rounds. States are receiving fewer Pfizer doses than expected, and it will take at least six months for widespread vaccination.

What is the significance of the emergency use authorization of the Moderna vaccine?

How do the storage requirements of Moderna's vaccine compare to Pfizer's vaccine?

Who are the first groups expected to receive the vaccines?

What challenges are being faced regarding the distribution of the Pfizer vaccine?

What is the expected timeline for most Americans to be vaccinated?